SCIENTURE HOLDINGS INC
SCNX · NASDAQ
Updated at 2026-10-14 09:31:18
- Today's High
- $3.93
- Today’s Low
- $3.24
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.79
- Previous Close
- $3.91
- Volume
- 37.7K
- Market Cap
- $6.42M
- P/E Ratio
- --
- EPS
- $-0.34
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- PHARMACEUTICAL RETAILERS
- Headquarters
- 20 AUSTIN BOULEVARD, COMMACK, NY, UNITED STATES, 11725
- Country
- US
- Listing Date
- 2020-02-18
- Fiscal Year End
- December
- Shares Outstanding
- 40.63M
- CIK
- 0001382574
- Website
- www.trxadehealth.com
Scienture Holdings, Inc. (SCNX) is a pioneering biotechnology firm focused on transforming the treatment landscape for neurological disorders through its advanced drug development pipeline and a seasoned research team. The company is dedicated to addressing significant unmet medical needs, highlighting its potential to enhance patient outcomes while skillfully navigating regulatory complexities. With a strong emphasis on scientific integrity and strategic collaborations, Scienture is well-positioned to leverage growth opportunities in the burgeoning global healthcare market, particularly as the demand for effective neurological therapies continues to rise.
Financial Metrics
Revenue
2026-06-30
$343.63K
2026-03-31
$56.32K
2025-12-31
-$168.69K
2025-09-30
$590.05K
Operating Expenses
2026-06-30
$3.03M
2026-03-31
$3.09M
2025-12-31
$2.91M
2025-09-30
$4.93M
Net Income
2026-06-30
-$2.82M
2026-03-31
-$3.4M
2025-12-31
-$28.12M
2025-09-30
-$3.6M
Net Profit Margin
2026-06-30
-821.31%
2026-03-31
-6.04K%
2025-12-31
16.66K%
2025-09-30
-611.36%
Earnings Per Share
2026-06-30
$-0.07
2026-03-31
$-0.08
2025-12-31
$-0.13
2025-09-30
$-0.19
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$2.23M
2026-03-31
-$2.89M
2025-12-31
-$28.7M
2025-09-30
-$1.79M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
6.62%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $343.63K | $56.32K | -$168.69K | $590.05K |
| Operating Expenses | $3.03M | $3.09M | $2.91M | $4.93M |
| Net Income | -$2.82M | -$3.4M | -$28.12M | -$3.6M |
| Net Profit Margin | -821.31% | -6.04K% | 16.66K% | -611.36% |
| Earnings Per Share | $-0.07 | $-0.08 | $-0.13 | $-0.19 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$2.23M | -$2.89M | -$28.7M | -$1.79M |
| Effective Tax Rate | -- | -- | 6.62% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.